NEW YORK, April 3 - Myriad Genetics said today that it was tapped by DuPont to help the chemical giant's agbio division build a better seed.

Myriad will get $24 million over two years to apply its genomic-sequencing technology and bioinformatics experience to collect and deliver certain molecular-genetic information to the unit, Pioneer.

Financial details of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.